Example case 4
Home / Reports / Example case 4

Example case 4

Findings and treatment report

Male patient, age 46


  • Multiple sclerosis [Encephalomyelitis disseminata], relapsing, progressive.
  • Polyneuropathy not described further
  • Disorders of inflammatory metabolism with genetic inflammation level 3
  • Immune system disorder with prevalent antibody deficiency, not further described
  • Stage III Lyme borreliosis, stage III Lyme neuroborreliosis
  • Motor sensory paraplegia (TH4)
  • Marked paraparesis


Apheresis, whole body hyperthermia, curcumin intravenous

Equipment used and treatment concept:

Moderate whole body hyperthermia with heckel-HT 3000 /whole body hyperthermia device – Manufacturer:
Hydrosun Medizintechnik GmbH). Duration of treatment, approx. 3-4 hours, depending on individual progress taking into account heart rate, oxygen saturation and mental state.

Methodological principle:

  • Heat introduced via skin-tolerable, deep-acting water filtered IR-A radiation (wIRA) directly into the blood-suffused tissue.
  • Fast, well tolerable increase of core body temperature.
  • Good compliance even during application lasting several hours.
  • Good lying comfort on adjustable hospital bed.
  • Immediate change to heat build-up (possibly lasting several hours) during which the patient’s position can be switched steplessly between lying and sitting.
  • Mobile treatment unit without water or high current connection.
  • Continuous measurement and monitoring of core temperature, heart rate, oxygen saturation, blood pressure, ECG, breathing rate


The patient suffers from severe motor dysfunctions and pain. A pronounced feature (besides the diagnoses given above) is that relapses occur constantly caused by inflammations. These are expressed as increased pain, joint complaints and severe restriction of the already extremely limited ability to move. Laboratory examinations (TNF-alpha inhibitor test performed by IMD Berlin) and clinical response showed that curcuma had a strong anti-inflammatory effect for the patient. The infusion was therefore employed to address the relapses and the associated motor limitations directly and effectively. This was therefore introduced as complementary therapy with hyperthermia.

Upon review of the findings available and a physical examination of the patient, it is noticeable that various chronic infections, weak immune system and a permanently relatively low body temperature (core body temperature 35.7 – 36.3 °C) are accompanied by an inability to perspire. Also conspicuous are severe circulatory disorders in the extremities, which are constantly cold.

At our centre, we perform plasmaphereses to treat the immunological disorders with good effect. The aim is to reduce the frequency of the required plasmaphereses permanently and sustainably – while at the same time stabilising the overall health status. The hyperthermia treatments can be beneficial to this purpose.

Hyperthermia is clinically effective in cases of chronic inflammatory diseases, chronic joint changes (e.g., arthroses), circulatory disorders, and has been found to be effective in cases of chronic infections and a weakened immune system. There are no contraindications for this patient.

Zentrum der Erweiterten Medizin